The impact of dietary calcium intake and vitamin D status on the effects of zoledronate

Osteoporosis International

Volumn 24, Issue 1, 2013, Pages 349-354

  Bourke, S ^a   Bolland, M J ^b   Grey, A ^b   Horne, A M ^b   Wattie, D J ^b   Wong, S ^b   Gamble, G D ^b   Reid, I R ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Acute phase reaction; Bone mineral density; Dietary calcium intake; Vitamin D; Zoledronate

Indexed keywords

CALCIFEDIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PARACETAMOL; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; VITAMIN D; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIP; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; VITAMIN D DEFICIENCY;

ACUTE-PHASE REACTION; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCIUM, DIETARY; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD-DRUG INTERACTIONS; HIP JOINT; HUMANS; IMIDAZOLES; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84872351272     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-2117-4     Document Type: Article

References (16)

1. Adami S, Giannini S, Bianchi G et al (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20:239-244
2. Carmel AS, Shieh A, Bang H et al. (2012) The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml. Osteoporos Int (in press)
3. Antoniucci DM, Vittinghoff E, Palermo L et al (2009) Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int 20:1259-1266
4. Bonnick S, Broy S, Kaiser F et al (2007) Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin 23:1341-1349
5. McCloskey EV, Beneton M, Charlesworth D et al (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22:135-141
6. Grey A, Bolland MJ, Wattie D et al (2009) The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab 94:538-544
7. Grey A, Bolland M, Wattie D et al (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251-2255
8. Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809-1822
9. Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799-1809
10. Reid IR, Gamble GD, Mesenbrink P et al (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95:4380-4387
11. Bertoldo F, Pancheri S, Zenari S et al (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25:447-454
12. Grey A, Bolland M, Wong S et al (2012) Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 97:286-292
13. Angus RM, Sambrook PN, Pocock NA et al (1989) A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89:209-214
14. Antoniucci DM, Vittinghoff E, Blackwell T et al (2005) Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab 90:4566-4572
15. Dawson-Hughes B, Chen P, Krege JH (2007) Response to teriparatide in patients with baseline 25-hydroxyvitamin D insufficiency or sufficiency. J Clin Endocrinol Metab 92:4630-4636
16. Bolland MJ, Bacon CJ, Horne AM et al (2010) Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr 91:82-89